ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Dr. Leonard G. Horowitz Issues Legal Notice Urging Investigation into COVID-19 Research Origins and Vaccine Technologies





Health Freedom Advocate Submits Legal Notice to HHS, NIH, and DOJ Calling for Investigation into COVID-19 Origins and Related Research Practices

LAS VEGAS, NV, June 10, 2025 /24-7PressRelease/ -- Dr. Leonard G. Horowitz, a Harvard-trained researcher in emerging diseases and Editor-in-Chief of Medical Veritas International Inc., has issued a formal legal "Notice and Demand" addressed to U.S. Health and Human Services Secretary Robert F. Kennedy Jr., National Institutes of Health Director Dr. Jay Bhattacharya, and U.S. Attorney General Pam Bondi. The notice calls for further examination of the origins of COVID-19 and the technologies used in response efforts, including vaccine delivery systems.

According to Dr. Horowitz, the notice outlines concerns about the possible role of international gain-of-function research in the emergence of COVID-19, referencing collaborative efforts between U.S. and Chinese institutions. It highlights figures such as Dr. Ralph Baric (UNC), Dr. Charles Lieber (Harvard), Dr. Robert Langer (MIT), and former NIAID Director Dr. Anthony Fauci as individuals of interest for review. The document raises questions about whether certain research and public health responses warrant independent investigation.

Among the topics addressed in the notice are the use of novel nanotechnologies in vaccine delivery—including mRNA platforms and hydrogel components. Dr. Horowitz asserts that some of these systems may be linked to adverse health outcomes, including neurological, cardiovascular, and immunological complications, and recommends further scientific review of these claims.

The document also critiques the U.S. government's handling of related oversight, including a recent Executive Order on biological research safety. Dr. Horowitz contends that current federal guidelines may not go far enough in addressing risks from domestic programs.

"This notice is meant to encourage transparency, accountability, and a science-based review of evidence," said Dr. Horowitz. "We believe the public deserves a fair and open discussion about the origins of COVID-19, the technologies used to address it, and the regulatory processes involved."

Medical Veritas International Inc., a nonprofit organization, has made the notice, supporting exhibits, and a summary video available to the public at MedicalVeritas.org. Dr. Horowitz, author of the book Emerging Viruses: AIDS & Ebola—Nature, Accident or Intentional?, invites scientists, policymakers, and independent media to evaluate the materials and contribute to a constructive, fact-based dialogue.

For media inquiries, please contact: Dr. Leonard G. Horowitz
Editor-in-Chief, Medical Veritas International Inc.
Email: editor@medicalveritas.org
Phone: (310) 877-3002

Medical Veritas International Inc. is a 501(c)(3) nonprofit dedicated to advancing public health by exposing censored truths about emerging diseases and Big Pharma's misconduct. The organization publishes peer-reviewed science and advocates for transparency in medicine and governance.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.